Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Mortality and suicide risk in treatment-resistant depression: an observational study of the long-term impact of intervention.

Olin B, Jayewardene AK, Bunker M, Moreno F.

PLoS One. 2012;7(10):e48002. doi: 10.1371/journal.pone.0048002. Epub 2012 Oct 25.

2.

A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and Suicidality.

Aaronson ST, Sears P, Ruvuna F, Bunker M, Conway CR, Dougherty DD, Reimherr FW, Schwartz TL, Zajecka JM.

Am J Psychiatry. 2017 Jul 1;174(7):640-648. doi: 10.1176/appi.ajp.2017.16010034. Epub 2017 Mar 31. Erratum in: Am J Psychiatry. 2017 Sep 1;174(9):907.

PMID:
28359201
4.

A Novel Brief Therapy for Patients Who Attempt Suicide: A 24-months Follow-Up Randomized Controlled Study of the Attempted Suicide Short Intervention Program (ASSIP).

Gysin-Maillart A, Schwab S, Soravia L, Megert M, Michel K.

PLoS Med. 2016 Mar 1;13(3):e1001968. doi: 10.1371/journal.pmed.1001968. eCollection 2016 Mar.

5.

Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial.

Bruce ML, Ten Have TR, Reynolds CF 3rd, Katz II, Schulberg HC, Mulsant BH, Brown GK, McAvay GJ, Pearson JL, Alexopoulos GS.

JAMA. 2004 Mar 3;291(9):1081-91.

PMID:
14996777
6.

The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.

KoKoAung E, Cavenett S, McArthur A, Aromataris E.

JBI Database System Rev Implement Rep. 2015 Apr 17;13(3):174-205. doi: 10.11124/jbisrir-2015-2272. Review.

PMID:
26447056
7.

Efficacy of vagus nerve stimulation in the treatment of depression.

Grimm S, Bajbouj M.

Expert Rev Neurother. 2010 Jan;10(1):87-92. doi: 10.1586/ern.09.138. Review.

PMID:
20021323
8.

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.

Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA.

JAMA. 2007 Apr 18;297(15):1683-96.

PMID:
17440145
9.

Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.

Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD008324. doi: 10.1002/14651858.CD008324.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;11:CD008324.

PMID:
23152255
10.

Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study.

Alexopoulos GS, Reynolds CF 3rd, Bruce ML, Katz IR, Raue PJ, Mulsant BH, Oslin DW, Ten Have T; PROSPECT Group.

Am J Psychiatry. 2009 Aug;166(8):882-90. doi: 10.1176/appi.ajp.2009.08121779. Epub 2009 Jun 15.

11.

Occurrence and course of suicidality during short-term treatment of late-life depression.

Szanto K, Mulsant BH, Houck P, Dew MA, Reynolds CF 3rd.

Arch Gen Psychiatry. 2003 Jun;60(6):610-7.

PMID:
12796224
12.

Vagus nerve stimulation in treatment-resistant depression: acute and follow-up results of an italian case series.

Dell'Osso B, Oldani L, Palazzo MC, Balossi I, Ciabatti M, Altamura AC.

J ECT. 2013 Mar;29(1):41-4. doi: 10.1097/YCT.0b013e3182735ef0.

PMID:
23303420
13.

Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study.

Albert U, Maina G, Aguglia A, Vitalucci A, Bogetto F, Fronda C, Ducati A, Lanotte M.

BMC Psychiatry. 2015 Mar 31;15:64. doi: 10.1186/s12888-015-0435-8.

14.

Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior.

Oquendo MA, Galfalvy H, Sullivan GM, Miller JM, Milak MM, Sublette ME, Cisneros-Trujillo S, Burke AK, Parsey RV, Mann JJ.

JAMA Psychiatry. 2016 Oct 1;73(10):1048-1055. doi: 10.1001/jamapsychiatry.2016.1478.

PMID:
27463606
15.

The efficacy of an opportunistic cognitive behavioral intervention package (OCB) on substance use and comorbid suicide risk: a multisite randomized controlled trial.

Morley KC, Sitharthan G, Haber PS, Tucker P, Sitharthan T.

J Consult Clin Psychol. 2014 Feb;82(1):130-40. doi: 10.1037/a0035310. Epub 2013 Dec 23.

PMID:
24364795
16.

Medicare patient experience with vagus nerve stimulation for treatment-resistant depression.

Feldman RL, Dunner DL, Muller JS, Stone DA.

J Med Econ. 2013;16(1):62-74. doi: 10.3111/13696998.2012.724745. Epub 2012 Sep 17.

PMID:
22954061
17.

Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults.

Sareen J, Cox BJ, Afifi TO, de Graaf R, Asmundson GJ, ten Have M, Stein MB.

Arch Gen Psychiatry. 2005 Nov;62(11):1249-57.

PMID:
16275812
18.

BDNF promoter methylation and suicidal behavior in depressive patients.

Kang HJ, Kim JM, Lee JY, Kim SY, Bae KY, Kim SW, Shin IS, Kim HR, Shin MG, Yoon JS.

J Affect Disord. 2013 Nov;151(2):679-85. doi: 10.1016/j.jad.2013.08.001. Epub 2013 Aug 13.

PMID:
23992681
19.

Suicidal ideation and attempts among psychiatric patients with major depressive disorder.

Sokero TP, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Isometsä ET.

J Clin Psychiatry. 2003 Sep;64(9):1094-100.

PMID:
14628986
20.

Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder.

Chronis-Tuscano A, Molina BS, Pelham WE, Applegate B, Dahlke A, Overmyer M, Lahey BB.

Arch Gen Psychiatry. 2010 Oct;67(10):1044-51. doi: 10.1001/archgenpsychiatry.2010.127.

Supplemental Content

Support Center